The trademark application was filed by GlaxoSmithKline Consumer Healthcare (UK) IP Limited, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on April 18, 1999, and it was registered by office on November 18, 1999 without any oppositions.
The application was filed in English (French was selected as the second language).
Two renewals of the trademark were recorded, one on March 11, 2007, and the other one on December 27, 2017.
of the trademark registration was recorded on March 11, 2007. of the trademark registration was recorded on December 27, 2017. Deletion of the representative of the trademark registration was recorded on November 13, 2006. Claims of seniority of the trademark registration was recorded on June 17, 2007. Change of name and address of the trademark registration was recorded on June 17, 2007. Change of name and professional address of the trademark registration was recorded on July 1, 2007. Appointment and Replacement of representative of the trademark registration was recorded on September 10, 2007. A transfer of the trademark registration was recorded on February 13, 2008. Change of name and address of the trademark registration was recorded on March 19, 2013. Change of name and professional address of the trademark registration was recorded on August 27, 2013. Appointment and Replacement of representative of the trademark registration was recorded on September 1, 2013. A transfer of the trademark registration was recorded on April 28, 2016.
The application claimed as seniority of the United Kingdom of Great Britain and Northern Ireland trademark 2125182 registered on February 20, 1997 and filed on February 20, 1997 which was accepted by the office.